CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

India’s Tarsons Products raises $41.2m from anchor investors

By Vinu Lal

07:07, 15 November 2021

Medical equipment and devices in modern-day operation theatre in hospitals
The life sciences firm produces bench-top laboratory equipment – Photo: Shutterstock

Indian life sciences firm Tarsons Products raised INR3.06bn ($41.15m) from 32 anchor investors ahead of its initial share sale to the public which opened today, according to a regulatory update.

The West Bengal-based company allotted 4.62 million shares at the upper price band of INR662 per share. Earlier on 10 November, Tarsons Products had fixed a price band of INR635-INR662 a share for its INR10.24bn ($138m) initial public offering (IPO) to the public.

First Sentier Investors subscribed to 9.80%, Nippon Life India Trustee invested in lieu of an 8.99% of the anchor investor portion and the government of Singapore with an 8.66% share were among the top investors, according to the release published on 12 November.

Pinebridge Global Funds (7.57%), Abu Dhabi Investment Authority (7.57%), Mirae Asset Healthcare Fund (7.57%) and Aditya Birla Sun Life Trustee (5.36%) were among the other investors in the company.

Fresh issue and offer for sale

Tarsons Products is a labware firm engaged in the designing, development, manufacturing and marketing of consumables, reusables and others. These include benchtop equipment used in various laboratories, academic institutes, pharmaceutical companies, diagnostic companies and hospitals.


1.26 Price
-0.310% 1D Chg, %
Long position overnight fee -0.0046%
Short position overnight fee -0.0036%
Overnight fee time 22:00 (UTC)
Spread 0.00013


147.37 Price
+0.150% 1D Chg, %
Long position overnight fee 0.0112%
Short position overnight fee -0.0194%
Overnight fee time 22:00 (UTC)
Spread 0.010


1.08 Price
-0.310% 1D Chg, %
Long position overnight fee -0.0080%
Short position overnight fee -0.0003%
Overnight fee time 22:00 (UTC)
Spread 0.00006


0.65 Price
-0.030% 1D Chg, %
Long position overnight fee -0.0074%
Short position overnight fee -0.0008%
Overnight fee time 22:00 (UTC)
Spread 0.00006

Tarsons Products’ IPO comprises a fresh issue of up to INR1.5bn and an offer for sale (OFS) of up to 13.2 million shares by existing investors in the company, according to the company’s Red Herring Prospectus or final papers filed with the domestic market regulator Securities and Exchange Board of India.

Existing investors in the company including Sanjive Sehgal (390,000 shares), Rohan Sehgal (310,000 shares) and Clear Vision Investment Holdings (12.50 million shares) would be tendering shares through the offer. The offer includes a reservation of up to 60,000 shares for employees.

ICICI Securities, Edelweiss Financial Services and SBI Capital Markets are managers to the issue. The firm proposes to list the shares after the IPO on both BSE and National Stock Exchange.

Read More: India’s Droom Technology files early papers for IPO

Related topics

Rate this article

Capital Com is an execution-only service provider. The material provided on this website is for information purposes only and should not be understood as an investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page then you do so entirely on your own risk.

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading